Puma Biotechnology Inc (PBYI)
4.83
+0.08
(+1.68%)
USD |
NASDAQ |
May 08, 16:00
4.835
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Total Return Level: 4.83 for May 8, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 08, 2024 | 4.83 |
May 07, 2024 | 4.75 |
May 06, 2024 | 4.62 |
May 03, 2024 | 4.86 |
May 02, 2024 | 4.96 |
May 01, 2024 | 4.95 |
April 30, 2024 | 5.07 |
April 29, 2024 | 5.02 |
April 26, 2024 | 5.02 |
April 25, 2024 | 4.88 |
April 24, 2024 | 4.83 |
April 23, 2024 | 5.13 |
April 22, 2024 | 5.17 |
April 19, 2024 | 5.01 |
April 18, 2024 | 4.99 |
April 17, 2024 | 5.17 |
April 16, 2024 | 5.10 |
April 15, 2024 | 5.35 |
April 12, 2024 | 5.27 |
April 11, 2024 | 5.49 |
April 10, 2024 | 5.525 |
April 09, 2024 | 5.83 |
April 08, 2024 | 5.63 |
April 05, 2024 | 5.66 |
April 04, 2024 | 5.51 |
Date | Value |
---|---|
April 03, 2024 | 5.35 |
April 02, 2024 | 5.28 |
April 01, 2024 | 5.28 |
March 28, 2024 | 5.30 |
March 27, 2024 | 5.58 |
March 26, 2024 | 5.60 |
March 25, 2024 | 5.59 |
March 22, 2024 | 5.33 |
March 21, 2024 | 5.35 |
March 20, 2024 | 4.695 |
March 19, 2024 | 4.30 |
March 18, 2024 | 4.66 |
March 15, 2024 | 5.00 |
March 14, 2024 | 5.22 |
March 13, 2024 | 5.33 |
March 12, 2024 | 5.35 |
March 11, 2024 | 5.49 |
March 08, 2024 | 5.35 |
March 07, 2024 | 5.75 |
March 06, 2024 | 5.53 |
March 05, 2024 | 5.18 |
March 04, 2024 | 5.36 |
March 01, 2024 | 5.89 |
February 29, 2024 | 6.22 |
February 28, 2024 | 6.60 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.64
Minimum
May 11 2022
30.02
Maximum
May 09 2019
6.702
Average
6.12
Median
Oct 08 2021
Total Return Level Benchmarks
ADMA Biologics Inc | 6.86 |
Pfizer Inc | 96.62 |
Sarepta Therapeutics Inc | 132.58 |
Immunogen Inc (DELISTED) | -- |
United Therapeutics Corp | 261.09 |